Related Experiment Video
Updated: Aug 8, 2025
08:06
Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
31.7K
Impaired dopamine release in Parkinson's disease
Kaitlyn M L Cramb1,2,3, Dayne Beccano-Kelly1, Stephanie J Cragg1,2
1Oxford Parkinson's Disease Centre and Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, OX1 3QU, UK.
Brain : a Journal of Neurology
|March 3, 2023
Summary
Early Parkinson's disease involves dopamine release deficits before neuron loss, not just after. This dysfunction, linked to genetic factors, may be a key early sign of the neurodegenerative condition.
Area of Science:
- Neuroscience
- Neurology
- Molecular Biology
Background:
- Parkinson's disease (PD) is a common neurodegenerative disorder with unclear early mechanisms.
- Motor deficits in PD are often attributed to dopaminergic neuron loss and reduced dopamine, but this view may be incomplete.
Approach:
- This review synthesizes evidence from various Parkinson's disease models.
- It examines the mechanisms underlying dopamine release deficits occurring before neurodegeneration.
Key Points:
- Evidence suggests dopamine release dysfunction precedes significant neuronal loss in Parkinson's disease.
- Impaired dopamine release can stem from disruptions in diverse PD-associated genetic and molecular pathways.
- Axonal dopamine release dysregulation is a potential early pathophysiological hallmark of Parkinson's disease.
Conclusions:
- Dopamine release deficits represent a critical, potentially early, pathophysiological event in Parkinson's disease.
- Understanding these pre-neurodegenerative mechanisms is crucial for developing effective early diagnostic and therapeutic strategies.
Related Concept Videos
01:24Parkinson's Disease: Treatment
325
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
325
01:15Parkinson's Disease: Overview
636
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
636
01:37Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
01:29Drugs Affecting Neurotransmitter Synthesis
1.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.5K
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
812
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
812
01:22Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K